{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:27:04Z","timestamp":1787660824084,"version":"build-2736575974"},"reference-count":30,"publisher":"Society of Nuclear Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,4,10]]},"published-print":{"date-parts":[[2026,8]]},"DOI":"10.2967\/jnumed.125.271707","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:55:11Z","timestamp":1778770511000},"page":"1216-1222","source":"Crossref","is-referenced-by-count":0,"title":["Management of Hemodialyzed Patients Treated with Radioactive Iodine for Thyroid Cancer: How Could We Improve It? Tracks from the Lille Experience"],"prefix":"10.2967","volume":"67","author":[{"given":"Benjamin","family":"Chevalier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Devos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clio","family":"Baillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Jannin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Fages","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9reng\u00e8re","family":"Dekyndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Do Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Huglo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Prov\u00f4t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Beron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Lion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Maurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"2026082505101223000_67.8.1216.1","doi-asserted-by":"publisher","DOI":"10.1177\/10507256251363120"},{"key":"2026082505101223000_67.8.1216.2","first-page":"15N","article-title":"SNMMI procedure standard\/EANM practice guideline for nuclear medicine evaluation and therapy of differentiated thyroid cancer: abbreviated version","volume":"63","author":"Avram","year":"2022","journal-title":"J Nucl Med."},{"key":"2026082505101223000_67.8.1216.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30045-3"},{"key":"2026082505101223000_67.8.1216.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-022-00542-7"},{"key":"2026082505101223000_67.8.1216.5","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/MNM.0b013e32831089e0","article-title":"The biodistribution of radioiodine on posttherapy iodine-131 scans in thyroid cancer patients with chronic renal failure","volume":"29","author":"Akta\u015f","year":"2008","journal-title":"Nucl Med Commun."},{"key":"2026082505101223000_67.8.1216.6","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1200\/JCO.21.01841","article-title":"Association between radioactive iodine treatment for pediatric and young adulthood differentiated thyroid cancer and risk of second primary malignancies","volume":"40","author":"Pasqual","year":"2022","journal-title":"J Clin Oncol."},{"key":"2026082505101223000_67.8.1216.7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s41181-021-00145-w","article-title":"Safe use of radiopharmaceuticals in patients with chronic kidney disease: a systematic review","volume":"6","author":"Schreuder","year":"2021","journal-title":"EJNMMI Radiopharm Chem."},{"key":"2026082505101223000_67.8.1216.8","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1002\/1097-0142(19901215)66:12<2509::AID-CNCR2820661211>3.0.CO;2-M","article-title":"131I treatment of thyroid papillary carcinoma in a patient with renal failure","volume":"66","author":"Morrish","year":"1990","journal-title":"Cancer."},{"key":"2026082505101223000_67.8.1216.9","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2005.15.1321"},{"key":"2026082505101223000_67.8.1216.10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/thy.1996.6.301","article-title":"Radioiodine treatment of thyroid carcinoma in patients on maintenance hemodialysis","volume":"6","author":"Daumerie","year":"1996","journal-title":"Thyroid."},{"key":"2026082505101223000_67.8.1216.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.232017"},{"key":"2026082505101223000_67.8.1216.12","unstructured":"Loevinger R Budinger TF Watson EE . MIRD Primer for Absorbed Dose Calculations. New York, NY: Society of Nuclear Medicine; 1991."},{"key":"2026082505101223000_67.8.1216.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0761-x"},{"key":"2026082505101223000_67.8.1216.14","first-page":"103","article-title":"Rating incidence of adverse effects after using recombinant TSH (rhTSH)","volume":"34","author":"Suligowska","year":"2018","journal-title":"Medical Studies\/Studia Medyczne."},{"key":"2026082505101223000_67.8.1216.15","unstructured":"Thyrogen. Summary of product characteristics. European Medicines Agency website. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/thyrogen. Updated February 19, 2025."},{"key":"2026082505101223000_67.8.1216.16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3401"},{"key":"2026082505101223000_67.8.1216.17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1525-139X.2004.17114.x","article-title":"Radioactive 131I use in end-stage renal disease: nightmare or nuisance?","volume":"17","author":"Rodby","year":"2004","journal-title":"Semin Dial."},{"key":"2026082505101223000_67.8.1216.18","first-page":"17-0111","article-title":"Dosing of radioactive iodine in end-stage renal disease patient with thyroid cancer","volume":"2017","author":"Bhat","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep."},{"key":"2026082505101223000_67.8.1216.19","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-54-639-259"},{"key":"2026082505101223000_67.8.1216.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.171397"},{"key":"2026082505101223000_67.8.1216.21","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s00259-023-06112-8","article-title":"A comparison of simplified protocols of personalized dosimetry in NEN patients treated by radioligand therapy (RLT) with [177Lu]Lu-DOTATATE to favor its use in clinical practice","volume":"50","author":"Palmese","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026082505101223000_67.8.1216.22","first-page":"363","article-title":"Iodine-131 pharmacokinetics in patients on hemodialysis for end stage renal disease: clinical implications","volume":"50","author":"Courbon","year":"2006","journal-title":"Q J Nucl Med Mol Imaging."},{"key":"2026082505101223000_67.8.1216.23","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/105072501753271716","article-title":"Iodine-131 treatment of thyroid papillary carcinoma in patients undergoing dialysis for chronic renal failure: a dosimetric method","volume":"11","author":"Jim\u00e9nez","year":"2001","journal-title":"Thyroid."},{"key":"2026082505101223000_67.8.1216.24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/MNM.0000000000000439","article-title":"Effects of hemodialysis on iodine-131 biokinetics in thyroid carcinoma patients with end-stage chronic renal failure","volume":"37","author":"Yeyin","year":"2016","journal-title":"Nucl Med Commun."},{"key":"2026082505101223000_67.8.1216.25","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2006.16.1019"},{"key":"2026082505101223000_67.8.1216.26","first-page":"1587","article-title":"Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer","volume":"47","author":"Tuttle","year":"2006","journal-title":"J Nucl Med."},{"key":"2026082505101223000_67.8.1216.27","first-page":"648","article-title":"Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal","volume":"47","author":"Hanscheid","year":"2006","journal-title":"J Nucl Med."},{"key":"2026082505101223000_67.8.1216.28","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-10-0071"},{"key":"2026082505101223000_67.8.1216.29","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/01.rlu.0000227013.36421.ce","article-title":"A pragmatic protocol for I-131 rhTSH-stimulated ablation therapy in patients with renal failure","volume":"31","author":"Driedger","year":"2006","journal-title":"Clin Nucl Med."},{"key":"2026082505101223000_67.8.1216.30","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4158\/EP.14.8.961","article-title":"Optimum recombinant human thyrotropin dose in patients with differentiated thyroid carcinoma and end-stage renal disease","volume":"14","author":"Pitoia","year":"2008","journal-title":"Endocr Pract."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.271707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:10:27Z","timestamp":1787659827000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.271707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,3]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.2967\/jnumed.125.271707"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.271707","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]}}}